Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2025. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765200018 | Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3765201019 | Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3765202014 | Estradiol 2.08 microgram/hour and norethindrone acetate 5.83 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Estradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator value | 5.83 | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | Norethisterone acetate | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Norethisterone acetate | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator value | 2.08 | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | Estradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Progesterone receptor agonist-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
SAME AS association reference set (foundation metadata concept)
FHIR